Abstract
Introduction
The incidence of cardiovascular diseases continues to increase, becoming one of the leading causes of mortality globally. The proper use of medication can greatly reduce the death rate by slowing the progression of the disease. Yet, many patients struggle with following their medication regimen due to various reasons. Effective treatment management relies on patients' self-care and understanding of their illness and medications, which can impact their adherence to taking their prescribed drugs. The objective of the study was to determine the prevalence of medication non-compliance among patients in two public and private tertiary care hospitals in Peshawar and to identify the factors that contribute to this behavior.
Material and methods
A comparative cross-sectional study design was employed for the research. The study was conducted at Hayatabad Medical Complex and Rehman Medical Institute in Peshawar, as these two hospitals provide care for a significant proportion of cardiovascular disease patients in the area. To assess adherence, a quantitative scale was devised with scores of 8 considered high adherence, scores between 6 and 7 considered medium adherence, and scores below 6 considered low adherence. The factors impacting medication non-adherence were analyzed using a self-administered questionnaire, which was developed following a preliminary study conducted at both hospitals.
Results
In total, 168 eligible patients from the two hospitals were given the questionnaire. Out of these patients, 107 (63.7%) were male, and 61 (36.3%) were female, with ages ranging from 19 to 84 and a mean age of 55.33. The level of medication adherence was calculated among the participants, with 20.2% reporting high adherence, 22.6% reporting medium adherence, and 57.1% reporting low adherence. The results showed that monthly income (p = 0.006), the presence of co-morbidities (p = 0.002), and the fear of addiction to medication (p = 0.048) were the main factors influencing medication adherence. In regression analysis with high adherence as the reference category and a 95% confidence interval, hospital affiliation was found to be significantly associated with adherence levels.
Conclusions
The study found that medication adherence among cardiovascular disease patients in private tertiary care hospitals is generally high. However, the level of adherence was seen to be impacted by the patient's monthly income. In light of this, the government should implement programs to reduce the cost of healthcare provision and increase affordability for patients.
Keywords: pilot projects, confidence intervals, health expenditures, financial stress, developing countries, cardiovascular diseases, oral medicines, medicines, adherence, non-adherence
Introduction
Background
Cardiovascular diseases, as the name indicates, are diseases of the heart and blood vessels. The four main types are coronary heart disease, stroke, peripheral vascular disease, and aortic disease [1]. Medication adherence is defined as the regular and continuous taking of prescribed medicine by the patient. C. Everett Koop, MD, stated that "Drugs don't work in patients who don't take them" [2].
A study conducted in Quetta, Pakistan, showed that there is a lack of education among patients regarding the benefits of medication adherence [3]. The mortality rate for cardiovascular diseases is expected to increase in developing countries such as Pakistan over the next couple of decades due to high life expectancy and changes in lifestyle. In fact, cardiovascular diseases have reached a state of epidemic in many developing countries around the world [4]. Studies done in the United States have shown that more than 60% of cardiovascular disease patients are reported to be non-adherent, which is a growing cause of concern [5]. The factors affecting adherence may be physician- or patient-related and can lead to significant expenditure on the healthcare system, estimated at roughly $396-$792 million [6]. By addressing the problem of non-adherence, a lot of unnecessary spending on healthcare can be avoided [7]. Non-adherence is a problem not only in developing countries but also in developed countries. It is estimated that each year, 125,000 deaths from cardiovascular diseases in the United States are caused by non-adherence [8]. Identifying non-adherence can help in successfully treating the condition. If left unidentified, non-adherence can lead physicians to intensify the drug regimen, which in turn can lead to undesired outcomes and a burden on the economic state [9,10].
Physicians must understand that poor medication adherence is one of the reasons for below par clinical benefits. The World Health Organization (WHO) states that increasing medication adherence has a greater impact on health than improving specific treatments [11]. Therefore, physicians should identify strategies to improve medication adherence within the limits of their practice to enhance therapeutic outcomes. This approach should be carried out with the support and involvement of all individuals involved in medication use [12]. High medication adherence is associated with a decrease in emergency department visits, a decrease in hospitalization days, and a decrease in a person's pharmacy spending [13].
Medication non-adherence has been a growing concern in our community as many people do not adhere to the drug regimen prescribed by their doctor, leading to further complications of their disease. As a developing country, the financial burden increases on individuals and the government to provide proper health services. This cannot be done until patients observe medication adherence.
There have been no previous studies conducted in this region with this scope. Our study aims to calculate the frequency of medication non-adherence and identify various factors such as demographics; illness; and patient-, physician-, and medication-related factors associated with non-adherence.
The study aims to assess the incidence of non-compliance with medication among patients suffering from cardiovascular disease who seek treatment at both public and private tertiary care hospitals. It also endeavors to uncover the factors contributing to medication non-adherence among these patients in both types of healthcare facilities.
Materials and methods
Study design
This study utilized a comparative cross-sectional design and was conducted during the months of April and May in 2016. The sample size was calculated using the WHO sample calculator and was found to be 168, divided equally between both public and private tertiary care hospitals in Peshawar. The frequency of medication non-adherence was compared in both hospitals, and various factors affecting medication adherence were calculated.
Setting
Data was collected from the outpatient department of two tertiary care hospitals in Peshawar: Hayatabad Medical Complex, a public sector tertiary care hospital located in Hayatabad, Peshawar, where around 150 patients visit the cardiology outpatient department daily, and Rehman Medical Institute, a private sector tertiary care hospital located in Hayatabad, Peshawar, where around 60 patients visit the cardiology outpatient department daily.
Participants
Study participants were identified based on clearly defined selection criteria. Patients who have been using cardiovascular disease medication for more than six months were included, while patients who were being supported by any government or private organizations, have dementia and other neuronal degenerative problems, and were dependent on others for taking their medications were excluded.
Study size
A study conducted in India showed medication non-adherence among chronic diseases in about 11.76% of the patients, which was used as the prevalence to calculate the sample size from the WHO calculator and was found to be 168 (84 per hospital).
Variables
The variables that have a major impact on medication adherence were included in the analysis. These variables included marital status, income per month, education status, drug regimen, co-morbidities, alternate remedies, and confidence in the doctor. These variables were correlated with the level of adherence found among patients in both hospitals. The factors that affect medication adherence were divided into illness, medication, and physician-related factors.
Data collection and analysis
A self-structured questionnaire was used to gather data regarding all variables, and the data was analyzed using Statistical Package for Social Sciences (SPSS) version 16 (IBM SPSS Statistics, Armonk, NY). There was no difference in characteristics between the patients selected from the private and public sector tertiary care hospitals.
Quantitative variables
A quantitative scale was devised in which 8 would be considered high adherence, 6-8 medium adherence, and <6 low adherence. The association of adherence with different variables such as monthly income, literacy, number of drugs used, and co-morbidities in both the private and public tertiary care hospitals selected was also analyzed.
Statistical methods
The frequency of medication adherence was calculated using percentages. To compare the levels of adherence between the two types of hospitals, crosstabs were used, and the results were displayed in a pie chart format. A chi-square test was performed to determine the relationship between the level of adherence and various factors that may affect it. Additionally, multinomial logistic regression was employed to examine the significance of the association between medication adherence and other variables, with high adherence serving as the reference category.
Results
In total, 168 patients from the two hospitals who met the eligibility criteria were surveyed using questionnaires. Out of these participants, 107 (63.7%) were male, while 61 (36.3%) were female. The age range of the subjects was from 19 to 84 years old, with an average age of 55.33. Table 1 displays the percentage distribution of all variables studied, and Table 2 illustrates the distribution of gender with respect to medication adherence.
Table 1. Various variables described in both hospitals with confidence intervals (CI).
| Hayatabad Medical Complex | Rehman Medical Institute | |||||||
| Number | Percent | 95.0% Lower CI | 95.0% Upper CI | Number | Percent | 95.0% Lower CI | 95.0% Upper CI | |
| Male | 62 | 36.9% | 29.9% | 44.4% | 45 | 26.8% | 20.5% | 33.8% |
| Female | 22 | 13.1% | 8.6% | 18.8% | 39 | 23.2% | 17.3% | 30.0% |
| Married | 81 | 48.2% | 40.7% | 55.7% | 82 | 48.8% | 41.3% | 56.3% |
| Unmarried | 3 | 1.8% | 0.5% | 4.7% | 2 | 1.2% | 0.2% | 3.8% |
| <10,000 | 11 | 6.5% | 3.5% | 11.0% | 11 | 6.5% | 3.5% | 11.0% |
| 10,000-20,000 | 22 | 13.1% | 8.6% | 18.8% | 16 | 9.5% | 5.8% | 14.7% |
| 20,000-40,000 | 34 | 20.2% | 14.7% | 26.8% | 33 | 19.6% | 14.2% | 26.1% |
| 40,000-80,000 | 14 | 8.3% | 4.9% | 13.2% | 14 | 8.3% | 4.9% | 13.2% |
| >80,000 | 3 | 1.8% | 0.5% | 4.7% | 10 | 6.0% | 3.1% | 10.3% |
| Illiterate | 43 | 25.6% | 19.5% | 32.6% | 45 | 26.8% | 20.5% | 33.8% |
| Primary | 13 | 7.7% | 4.4% | 12.5% | 18 | 10.7% | 6.7% | 16.1% |
| Intermediate | 17 | 10.1% | 6.2% | 15.4% | 13 | 7.7% | 4.4% | 12.5% |
| Undergraduate | 10 | 6.0% | 3.1% | 10.3% | 6 | 3.6% | 1.5% | 7.2% |
| Postgraduate | 1 | 0.6% | 0.1% | 2.7% | 2 | 1.2% | 0.2% | 3.8% |
Table 2. Gender-wise distribution of patients on the basis of level of adherence.
| Gender of the Responder | ||||
| Male | Female | |||
| Level of Adherence | Low Adherence | Count (% Within the Level of Adherence) | 64 (66.7%) | 32 (33.3%) |
| Medium Adherence | Count (% Within the Level of Adherence) | 25 (65.8%) | 13 (34.2%) | |
| High Adherence | Count (% Within the Level of Adherence) | 18 (52.9%) | 16 (47.1%) | |
We hypothesized that there is a difference in the medication adherence of cardiovascular drugs among patients coming to public and private sector tertiary care hospitals, which was confirmed, and the null hypothesis was rejected.
The level of adherence was calculated among both hospitals and is described in Table 3. The level of adherence was cross-tabulated with both hospitals, and the strength of association was calculated using a chi-square test (α = 0.05), which was found to be highly significant (p = 0.000). This suggests that the hospitals are affecting the level of medication adherence among patients as given in Figure 1.
Table 3. Level of adherence in both hospitals.
| Level of Adherence | |||||
| Low Adherence | Medium Adherence | High Adherence | |||
| Name of the Hospital | Hayatabad Medical Complex | Count (% Within the Name of the Hospital) | 63 (75.0%) | 17 (20.2%) | 4 (4.8%) |
| Rehman Medical Institute | Count (% Within the Name of the Hospital) | 33 (39.3%) | 21 (25.0%) | 30 (35.7%) | |
Figure 1. Pie chart showing the overall percentage of adherence level in all patients.
Chi-square tests were carried out to find the strength of association between the level of adherence and the variables. Among the variables tested, income per month was found to be statistically significant (p = 0.006) in the private tertiary care hospital. Co-morbidities (other diseases) and addiction to medication were found statistically significant with p = 0.002 and 0.048, respectively, in the public tertiary care hospital.
A multinomial regression analysis was performed to determine if there was a significant correlation between the level of medication adherence and factors that impact it. High adherence was designated as the reference category, and a 95% confidence interval was used, as presented in Table 4.
Table 4. Multinomial regression analysis.
aThe reference category is high adherence
df: degrees of freedom
| Level of Adherencea | Standard Error | df | Significance | Exp(B) | 95% Confidence Interval for Exp(B) | ||
| Lower Bound | Upper Bound | ||||||
| Low Adherence | Intercept | 1.316 | 1 | 0.000 | |||
| Hospital | 0.585 | 1 | 0.000 | 0.068 | 0.022 | 0.215 | |
| Education | 0.207 | 1 | 0.375 | 0.833 | 0.555 | 1.248 | |
| Medium Adherence | Intercept | 1.395 | 1 | 0.023 | |||
| Hospital | 0.629 | 1 | 0.004 | 0.164 | 0.048 | 0.564 | |
| Education | 0.214 | 1 | 0.986 | 1.004 | 0.660 | 1.528 | |
Discussion
According to this study, the overall medication adherence was observed as low adherence, 57.1%; medium adherence, 22.6%; and high adherence, 20.2%. The patients of private tertiary care hospital showed a high adherence of 35% compared to 4.8% in the public tertiary care hospital. Income per month was the main variable, which was significant in this regard.
Few studies have been conducted in Pakistan regarding medication adherence among cardiovascular disease patients. A study conducted in Abbottabad, Pakistan, revealed that 68.14% of patients were having low medication adherence. This low adherence was found to be significantly associated with gender and socioeconomic status [14]. Similarly, another study was conducted on 460 patients at the Aga Khan University Hospital (AKUH) and National Institute of Cardiovascular Diseases, Karachi, from September 2005 to May 2006; 77% of the patients were found to have high adherence, and the significant factors associated with it were the number of drugs taken by the patient and the regularity of medication [15].
An Ethiopian study, conducted on 384 patients, revealed that 64.6% of the patients were adherent to their treatment. Gender, knowledge about treatment, distance from the hospital, and co-morbidities were significantly associated factors [16]. Another study conducted in Uzbekistan, on 209 patients, revealed that 36.8% of the patients had a low level of adherence; knowledge regarding the disease was significantly associated with low medication adherence [17]. A study conducted in India in 2022 revealed that medication adherence was 20.83%, 28.37%, and 32% in hypertension (HTN), congestive cardiac failure (CCF), and ischemic heart disease (IHD) patients, respectively [18]. A study conducted in rural India on 280 patients revealed that about 32% of the patients had low adherence [19].
Additionally, recent studies have found that factors such as language barriers, lack of social support, and cultural beliefs also play a role in medication non-adherence among cardiovascular disease patients [20,21]. A study conducted in the United States found that Hispanic patients had lower adherence rates compared to non-Hispanic patients, due to language barriers and the lack of cultural competence among healthcare providers [22]. Another study in the United Kingdom found that patients from South Asian backgrounds had lower adherence rates due to cultural beliefs and the lack of social support [23].
Thus, it appears that medication adherence among cardiovascular disease patients generally remains the same across different countries belonging to the Asian region among which income and co-morbidities tend to be significantly associated with adherence.
Limitations
This study is unable to establish a temporal sequence of events. There may also be recall bias due to the use of self-reported questionnaires.
Generalizability
The findings of this study can be extrapolated to other tertiary care hospitals within the same province or country, as the patient demographic and healthcare services tend to exhibit similarities.
Recommendation
It is necessary for the government to consider subsidizing healthcare costs to make healthcare services more affordable to low-income patients and the healthcare providers to take a patient-centered approach to healthcare delivery, which includes tailoring treatment plans to meet patients' individual needs and addressing their fears and concerns regarding medication use. By implementing these measures, we can improve medication adherence, enhance patient outcomes, and reduce the burden of cardiovascular disease on individuals and the society as a whole.
Conclusions
The findings of this study indicate that medication adherence among cardiovascular disease patients is higher in private sector tertiary care hospitals than in the public sector ones. Income, co-morbidities, and the fear of addiction were found to be significant factors affecting medication adherence. The government should consider implementing programs to subsidize the cost of healthcare to address the issue of low adherence among low-income patients.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Choices N. NHS: cardiovascular disease. http://www.nhs.uk/conditions/cardiovascular-disease/Pages/Introduction.aspx http://www.nhs.uk/conditions/cardiovascular-disease/Pages/Introduction.aspx
- 2.Medication adherence: its importance in cardiovascular outcomes. Ho PM, Bryson CL, Rumsfeld JS. Circulation. 2009;119:3028–3035. doi: 10.1161/CIRCULATIONAHA.108.768986. [DOI] [PubMed] [Google Scholar]
- 3.Association between knowledge and drug adherence in patients with hypertension in Quetta, Pakistan. F Saleem, MA Hassali, AA Shafie, Awad AG, Bashir S. http://www.tjpr.org/vol10_no2/2011_10_2_2_download.html Trop J Pharm Res. 2011;10:125–132. [Google Scholar]
- 4.Cardiovascular disease in South East Asia. Gul AM. http://www.pkheartjournal.com/index.php/pkheart/article/view/955 Pak Heart J. 2015;48:118–119. [Google Scholar]
- 5.Medication adherence in cardiovascular disease. Baroletti S, Dell’Orfano H. http://circ.ahajournals.org/content/121/12/1455. Circulation. 2010;121:1455–1458. doi: 10.1161/CIRCULATIONAHA.109.904003. [DOI] [PubMed] [Google Scholar]
- 6.Medication nonadherence: an unrecognized cardiovascular risk factor. Munger MA, Van Tassell BW, LaFleur J. http://www.pubmedcentral.nih.gov/articlerender.fcgi. MedGenMed. 2007;9:58. [PMC free article] [PubMed] [Google Scholar]
- 7.Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study. Hovstadius B, Petersson G. BMC Health Serv Res. 2011;11:326. doi: 10.1186/1472-6963-11-326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Merck Manual: adherence to a drug regimen. https://www.merckmanuals.com/professional/clinical-pharmacology/factors-affecting-response-to-drugs/adherence-to-a-drug-regimen 2022;8 [Google Scholar]
- 9.Nonadherence in difficult asthma - facts, myths, and a time to act. Lindsay JT, Heaney LG. http://www.pubmedcentral.nih.gov/articlerender.fcgi. Patient Prefer Adherence. 2013;7:329–336. doi: 10.2147/PPA.S38208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Non-adherence to cardiovascular medications. Kolandaivelu K, Leiden BB, O’Gara PT, Bhatt DL. http://eurheartj.oxfordjournals.org/content/early/2014/09/28/eurheartj.ehu364. Eur Heart J. 20147;35:3267–3276. doi: 10.1093/eurheartj/ehu364. [DOI] [PubMed] [Google Scholar]
- 11.Medication adherence: WHO cares? Brown MT, Bussell JK. http://10.4065/mcp.2010.0575. Mayo Clin Proc. 2011;86:304–314. doi: 10.4065/mcp.2010.0575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Patient medication adherence: measures in daily practice. Jimmy B, Jose J. http://www.ncbi.nlm.nih.gov/pubmed/22043406. Oman Med J. 2011;26:155–159. doi: 10.5001/omj.2011.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Medication adherence leads to lower health care use and costs despite increased drug spending. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. http://content.healthaffairs.org/cgi/doi/10.1377/hlthaff.2009.1087. Health Aff (Millwood) 2011;30:91–99. doi: 10.1377/hlthaff.2009.1087. [DOI] [PubMed] [Google Scholar]
- 14.Non-compliance to anti-hypertensive medication and its associated factors among hypertensives. Bilal A, Riaz M, Shafiq NU, Ahmed M, Sheikh S, Rasheed S. http://www.ncbi.nlm.nih.gov/pubmed/26182765. J Ayub Med Coll Abbottabad. 2015;27:158–163. [PubMed] [Google Scholar]
- 15.Factors associated with adherence to anti-hypertensive treatment in Pakistan. Hashmi SK, Afridi MB, Abbas K, et al. http://dx.plos.org/10.1371/journal.pone.0000280. PLoS One. 2007;2:0. doi: 10.1371/journal.pone.0000280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. Ambaw AD, Alemie GA, W/Yohannes SM, Mengesha ZB. BMC Public Health. 2012;12:282. doi: 10.1186/1471-2458-12-282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hypertension-related knowledge, practice and drug adherence among inpatients of a hospital in Samarkand, Uzbekistan. Malik A, Yoshida Y, Erkin T, Salim D, Hamajima N. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345680/ Nagoya J Med Sci. 2014;76:255–263. [PMC free article] [PubMed] [Google Scholar]
- 18.Patient and provider's perspective on barriers and facilitators for medication adherence among adult patients with cardiovascular diseases and diabetes mellitus in India: a qualitative evidence synthesis. Krishnamoorthy Y, Rajaa S, Rehman T, Thulasingam M. BMJ Open. 2022;12:0. doi: 10.1136/bmjopen-2021-055226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Assessment of adherence to cardiovascular medicines in rural population: an observational study in patients attending a tertiary care hospital. Santra G. http://www.ncbi.nlm.nih.gov/pubmed/26729949. Indian J Pharmacol. 2015;47:600–604. doi: 10.4103/0253-7613.169573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Factors that influence adherence to treatment plans amongst people living with cardiovascular disease: a review of published qualitative research studies. Rashidi A, Kaistha P, Whitehead L, Robinson S. Int J Nurs Stud. 2020;110:103727. doi: 10.1016/j.ijnurstu.2020.103727. [DOI] [PubMed] [Google Scholar]
- 21.Medication nonadherence before hospitalization for acute cardiac events. Kripalani S, Goggins K, Nwosu S, et al. http://10.1080/10810730.2015.1080331. J Health Commun. 2015;20:34–42. doi: 10.1080/10810730.2015.1080331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Evidence-based medication adherence in Hispanic patients with systolic heart failure in a disease management program. Hebert K, Beltran J, Tamariz L, Julian E, Dias A, Trahan P, Arcement L. Congest Heart Fail. 2010;16:175–180. doi: 10.1111/j.1751-7133.2010.00150.x. [DOI] [PubMed] [Google Scholar]
- 23.Adherence to cardiovascular medications in the South Asian population: a systematic review of current evidence and future directions. Akeroyd JM, Chan WJ, Kamal AK, Palaniappan L, Virani SS. World J Cardiol. 2015;7:938–947. doi: 10.4330/wjc.v7.i12.938. [DOI] [PMC free article] [PubMed] [Google Scholar]

